n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, February 27th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

General Cannabis Corp. (CANN)

StockOodles, Wealth Insider Alert, Market Intelligence Center Alert, StreetAuthority Daily, Promotion Stock Secrets, Marketbeat, TopPennyStockMovers, Wall Street Mover, Stockgoodies, PennyPro, Cannabis Financial Network News, Money Morning, SmallCapVoice, OTC Markets Group, and The Street reported on General Cannabis Corp. (CANN), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

General Cannabis Corp. is a service provider to businesses in the regulated cannabis industry. The Company’s mission is to lead the regulated cannabis industry through being a trusted partner to the cultivation, production and retail side of the cannabis business. A synergistic holding company, it formerly went by the name Advanced Cannabis Solutions, Inc. It changed its name to General Cannabis Corp. in June of 2015. General Cannabis is based in Denver, Colorado.

General Cannabis leases grow and related facilities - commercial real estate and equipment - to licensed business operators for their production needs. In addition, the Company is pursuing supplementary business products and services. These include customized finance, capital formation, banking, regulatory compliance consulting, security and advanced logistical support for grow operations.

The Company has strong operating divisions. These include real estate, consulting, security, and financing. Furthermore, General Cannabis distributes essential infrastructure products to grow facilities and dispensaries.

Chiefton Supply Co. is a wholly-owned subsidiary of General Cannabis. Chiefton Supply is a causal lifestyle brand. Chiefton Supply provides an alternative to the classic marijuana T-shirt. Chiefton creates street wear apparel and accessories for men and women. Also, General Cannabis’ Chiefton Design delivers high quality brand development and design to the legal cannabis market.

General Cannabis’ consulting division is Next Big Crop. This division provides practical experience and proven techniques for every phase of the cultivation, processing, and sale of cannabis. Services consist of business planning and application writing, to operations optimizations, management, and expansion.

Moreover, Iron Protection Group (IPG) is a wholly-owned subsidiary of General Cannabis. IPG provides security and training services to government agencies, multinational corporations, diplomats, dignitaries and non-profit organizations, domestically and around the world.

Combat veterans of the wars in Iraq and Afghanistan manage and operate Iron Protection Group. IPG covers all things related to protection. This is from training individuals in the art of manipulating a firearm, to providing a personal security detail for any of a client’s security requirements.

General Cannabis Corp. (CANN), closed Monday's trading session at $2.21, down 3.07%, on 287,235 volume with 492 trades. The average volume for the last 60 days is 261,469 and the stock's 52-week low/high is $0.37/$5.19.

Capstone Therapeutics Corp. (CAPS)

Wall Street Resources, Bestotc, and SmallCapVoice reported earlier on Capstone Therapeutics Corp. (CAPS), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Established in 1987, Capstone Therapeutics Corp. is a biotechnology company that centers on developing a pipeline of peptides and other molecules for helping patients with under-served medical conditions. The Company previously went by the name OrthoLogic Corp. It changed its corporate name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics is headquartered in Tempe, Arizona.

Capstone develops Apo E Mimetic Peptide Molecule AEM-28 and its analogs (by way of its LipimetiX Development, LLC joint venture (JV)), which play a critical role in lipoprotein metabolism. On August 3, 2012, Capstone Therapeutics entered into a JV, LipimetiX Development, LLC, to develop Apo E Mimetic Peptide Molecule AEM-28 and its analogs.

The JV has a development plan to pursue regulatory approval of AEM-28, or an analog, as treatment for Homozygous Familial Hypercholesterolemia (granted Orphan Drug Designation by the Food and Drug Administration (FDA) in 2012), Acute Pancreatitis, and other hyperlipidemic indications. The initial development plan extended through Phase 1a and 1b/2a clinical trials and was completed in Q4 of 2014.

Apolipoprotein E is a 299 amino acid protein. It plays a vital role in lipoprotein metabolism. AEM-28 is a 28 amino acid mimetic of Apo E and AEM-28-02 (an analog of AEM-28) is a 28 amino acid mimetic of Apo E (with an aminohexanoic acid group and a phospholipid).

AEM-28 and AEM-28-02, as Apo E mimetics, have the potential to enhance the clearance of triglyceride- and cholesterol-rich lipoproteins from the plasma, completing the reverse cholesterol transport pathway, and therefore reducing cardiovascular risk.

The JV has continued research into a new generation of chimeric Apo E peptides. It has discovered AEM-28-14, resulting in a provisional patent filing in 2015.  AEM-28-14 was found to be more potent (as tested in multiple animal models) than the parent molecule, AEM-28.

In December 2016, Capstone Therapeutics and LipimetiX Development, the Company’s drug development JV, announced that the JV’s lead commercial drug candidate, AEM-28-14, showed substantial and statistically-significant LDL cholesterol (LDLc) reductions in a hypercholesterolemic primate study at Wake Forest University.  Following a single IV administration of escalating doses up to 5mg/kg, LDLc exhibited a mean reduction of 64 percent from baseline at 24 hours, 46 percent from baseline at 3 days, and 16 percent from baseline at 7 days, notwithstanding the study animals remaining on a high fat/cholesterol diet through the full study.

Capstone Therapeutics Corp. (CAPS), closed Monday's trading session at $0.10, up 21.95%, on 263,457 volume with 37 trades. The average volume for the last 60 days is 27,304 and the stock's 52-week low/high is $0.035/$0.10.

Yew Bio-Pharm Group, Inc. (YEWB)

Greenbackers reported earlier on Yew Bio-Pharm Group, Inc. (YEWB), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Yew Bio-Pharm Group, Inc., by way of its operating entity, Harbin Yew Science and Technology Development Co., Ltd. (HDS), is a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine (TCM), handicraft products made from yew timber, and yew candle made with yew essence oil in China. The Company lists on the OTC BB. Established in 1996, Yew Bio-Pharm is based in Xiangfang District, Harbin City, Heilongjiang Province, China.

The Company employs a patented, accelerated growth technology to speed up the growth and maturity and commercialization of yew trees. Furthermore, it operates production facilities to manufacture yew handicrafts.

Yew Bio-Pharm’s patented Asexual Reproduction Method hastens the commercial viability of a yew tree. As a result, a yew tree can be used for commercialization starting in about three years, in comparison to more than 50 years for naturally grown yew trees.

Through this method, Yew Bio-Pharm can more than replenish the number of yew trees it cultivates and puts into production. The patented Asexual Reproduction Method was developed by Yew Bio-Pharm’s Founder and President, Mr. Zhiguo Wang. The Patent is valid through September 29, 2030.

Raw material from the species of yew tree that Yew Bio-Pharm grows contains taxol, and TCM containing yew raw materials has received approval as a traditional Chinese medicine (TCM) in China for the secondary treatment of certain cancers.

Yew Bio-Pharm grows Japanese yew trees (also known in China as Northeast yew trees), taxus cuspidata, on mountain hillsides near Harbin. It cultivates them in four nurseries it operates close to Harbin.

This past November, Yew Bio-Pharm Group reported financial results for the three- and nine-months ended September 30, 2016. Total revenues for Q3 2016 grew 194 percent to $15 million from $5.0 million a year prior. Sales of TCM raw materials amounted to 46.9 percent of total revenues. Net income for the three months ended September 30, 2016 rose 15.7 percent to $1.1 million from $933,514 in the same quarter the year prior.

Total revenues for the nine months of 2016 grew to $39.3 million from $12.3 million the year prior. Sales of TCM raw materials amounted to 61.2 percent of total revenues. Net income for the nine months of 2016 decreased 11.8 percent to $3.4 million from $3.9 million for the same period the year prior.

Moreover, Yew Bio-Pharm has now established a division to concentrate on organic foods and dietary supplements. The Company’s goal is to develop new business opportunities in related industries.

Yew Bio-Pharm Group, Inc. (YEWB), closed Monday's trading session at $0.25, down 24.24%, on 1,300 volume with 2 trades. The average volume for the last 60 days is 6,687 and the stock's 52-week low/high is $0.027/$1.00.

Nutra Pharma Corp. (NPHC)

Innovative Marketing, StocksToBuyNow, and PennyStocks24 reported earlier on Nutra Pharma Corp. (NPHC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nutra Pharma Corp. is a biotechnology company with its corporate headquarters in Coral Springs, Florida. The Company specializes in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. These include Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Nutra Pharma lists on the OTCQB.

The Company is marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market. Nutra Pharma, via its subsidiaries, carries out basic drug discovery research and clinical development. In addition, the Company seeks strategic licensing partnerships to lessen the risks associated with the drug development process.

Nutra Pharma’s holding, ReceptoPharm, is developing technologies for the production of drugs for HIV and MS. The Company's subsidiary, Designer Diagnostics, engages in the research and development (R&D) of diagnostic test kits designed to be used for the rapid identification of infectious diseases such as Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI).

Nutra Pharma offers a number of drug products for sale for pain treatment. One is Nyloxin®, the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Another is Nyloxin Extra Strength, the only non-narcotic and non-addictive treatment for severe (Stage 3) pain. In December 2014, Nutra Pharma launched Pet Pain-Away. This is the first OTC product to treat pain in companion animals without side effects.

The focus of Nutra Pharma's approach to drug discovery and the development of new therapeutic agents is founded on specialized receptor-binding proteins found in nature, especially those found in snake venom from the cobra. The Company’s leading drug candidates are RPI-MN and RPI-78M.

RPI-MN inhibits the entry of many viruses known to cause severe neurological damage in diseases such as encephalitis and AIDS. RPI-MN is undergoing development initially for the treatment of HIV. The Company’s RPI-78M is undergoing development for the treatment of multiple sclerosis (MS).

In 2016, Nutra Pharma announced a manufacturing alliance with Omnia Biologics. This alliance is to clone and produce alpha-cobratoxin for the production of RPI-78M for upcoming clinical trials in Pediatric Multiple Sclerosis. Nutra Pharma's MS drug was recently granted Orphan Status by the Food and Drug Administration (FDA) for the treatment of Pediatric Multiple Sclerosis.

Nutra Pharma Corp. (NPHC), closed Monday's trading session at $0.009, up 12.50%, on 656,454 volume with 19 trades. The average volume for the last 60 days is 1,000,752 and the stock's 52-week low/high is $0.004/$0.0255.

All for One Media Corp. (AFOM)

We are highlighting All for One Media Corp. (AFOM) today, here at the QualityStocks Daily Newsletter.

All for One Media Corp. is a tween marketing company whose shares trade on the OTC Markets Group’s OTCQB. The estimation is that the tween demographic is responsible for at least $260 billion yearly in direct sales in the U.S. alone. Called “Generation I” for "Internet," this generation's tweens represent the first demographic to have had only known life with the Internet and social media.

At present, the Company is producing "Crazy For the Boys," scheduled to commence principal photography this summer. All for One Media’s Chief Executive Officer is responsible for casting and producing the 90’s hit boy band, Dream Street. All for One Media has its corporate headquarters in Mount Kisco, New York.

In essence, All for One Media is a marketing brand changing the mindset of tweens that bullying is unacceptable. The Company, via entertainment, is working to deliver a message that will resonate with kids to impact the epidemic of bullying and cyber-bullying. It is also working to help individuals who’ve been affected by bullying to deal with it in a positive and constructive way.

The above-mentioned “Crazy For The Boys” is a full length coming of age musical dramedy. It features Groovy Tuesday music and choreography. This film tells the story of five high school girls from five very different cliques who must work together to run their school’s anti-bullying organization. The film features original pop songs regarding peer pressure, unrequited love, and teen angst.

The expectation is that “Crazy For The Boys” will generate revenues from numerous sources. These include domestic and global distribution, video on demand, merchandising, soundtrack, live performances, and other ancillary sources.

Last week, All for One Media announced that it named Wendy Starland as the Creative Consultant for the Company's film, "Crazy For The Boys." Starland is a well-renowned singer/songwriter. She has worked with Lady Gaga, The Black Eyed Peas, and The Wu Tang Clan.

Her music has been featured in a number of popular movies and TV shows, such as MTV's hit series' "The Hills” and ABC's "Regis and Kelly." Wendy Starland is also responsible for discovering and developing the creative and marketing strategy for multi-Grammy winner, Lady Gaga.

All for One Media Corp. (AFOM), closed Monday's trading session at $0.14, up 16.67%, on 69,295 volume with 14 trades. The average volume for the last 60 days is 35,866 and the stock's 52-week low/high is $0.08/$2.40.

graphic

The QualityStocks
Company Corner

graphic
graphic

eXp World Holdings, Inc. (EXPI)

The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $3.81, up 4.10%, on 2,500 volume with 8 trades. The stock’s average daily volume over the past 60 days is 12,578, and its 52-week low/high is $0.7094/$5.84.

eXp World Holdings Inc. the holding company for eXp Realty LLC, The Agent-Owned Cloud BrokerageŽ, has been invited to present at the 29th Annual ROTH Capital Partners Conference. The conference is being held on March 12-15, 2017 at the Ritz-Carlton, Laguna Niguel in Dana Point, California.

eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.

Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.

Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.

Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer

eXp World Holdings, Inc. Company Blog

eXp World Holdings, Inc. News:

eXp World Holdings to Present at Annual ROTH Conference

Super Bowl Quarterback Vince Ferragamo Joins eXp Realty

eXp World Holdings, Inc. to Host Corporate Update Webinar on February 23rd

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX). Today, ChineseInvestors.com closed trading at $1.23, off by 8.55%, on 246,967 volume with 231 trades. The stock’s average daily volume over the past 60 days is 178,215 and its 52-week low/high is $0.12/$2.75.

ChineseInvestors.com, Inc. today announces that company CEO Warren Wang attended Shangdong Yibao Biologics Co. Ltd.'s annual conference, and, by invitation, delivered a five-minute speech to celebrate the 18th anniversary of Yibao Biologics. ChineseInvestors.com recently launched www.ChineseCBDoil.com, marking the company's official entry into the CBD hemp oil markets.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com Blog

ChineseInvestors.com News:

ChineseInvestors.com Presents at Yibao Biologics' Annual Conference, Optimistic About Direct Selling Opportunity in China

Stealth Technologies Highlights Opportunities from Attendance at Leading Real Estate, Home Staging Conference

ChineseInvestors.com, Inc. to Present at the Disruptive Growth & Healthcare Conference in NYC on February 16, 2017

GreenStone Healthcare Corp. (GRST)

The QualityStocks Daily Newsletter would like to spotlight GreenStone Healthcare Corp. (GRST). Today, GreenStone Healthcare Corp. closed trading at $0.07015, up 7.92%, on 299,110 volume with 19 trades. The stock’s average daily volume over the past 60 days is 34,491, and its 52-week low/high is $0.015/$0.083.

GreenStone Healthcare Corp. (GRST), through its subsidiaries, provides medical services in the city of Toronto and the regional municipality of Muskoka, Ontario, Canada.

Located 90 minutes north of Toronto in Muskoka, GreenStone Healthcare's Addiction and Rehabilitation Treatments segment offers out-patient counseling, coaching, intervention, psychological assessment, and other related services.

GreeneStone Muskoka employs the best principles and practices currently available in the treatment of individuals with addiction. To ensure the most comprehensive and effective treatment for its clients, GreenStone Muskoka treats underlying or co-occurring disorders in tandem with the treatment of addiction.

The 36-bed addiction treatment center offers a holistic, individualized treatment approach to recovery. These private, paid programs vary in length from 45-90 days, depending on the unique needs of each resident and their response to the treatment.

GreenStone Muskoka also provides education and counseling sessions to educate the family members of its residents with the objective of helping them better understand the disease of addiction and how they should support their loved one throughout and after their recovery efforts.

GreenStone Healthcare President Shawn Leon has more than 25 years of experience managing public and private development-stage companies for various industries, including industrial minerals, aggregates, oil and gas, mining, financial, technology, hospitality and medical. He has provided financing and capital markets oversight for a number of these ventures, many of which have involved negotiations for mergers and acquisitions. He is joined by Vice President Dr. Anita Teslak, whose 25 years of combined experience as a CEO, psychologist and leadership provides valuable insight into a successful business model. Disclaimer

GreenStone Healthcare Corp. Company Blog

GreenStone Healthcare Corp. News:

GreeneStone Buys Canadian Real Estate Assets, Sells Canadian Addiction Treatment Business, and Acquires Addiction Treatment Business in Florida

GreeneStone Signs Definitive Agreement to Acquire Seastone of Delray, a Florida Limited Liability Company

GreeneStone Signs LOI to Acquire Aurora Recovery

ORHub, Inc. (ORHB)

The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $0.78, up 4.00%, on 160,505 volume with 73 trades. The stock’s average daily volume over the past 60 days is 12,499 and its 52-week low/high is $0.05/$2.09.

ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.

The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.

Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.

Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.

In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.

ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.

The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.

ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.

Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer

ORHub, Inc. Blog

ORHub, Inc. News:

ORhub, Inc. (ORHB) Engages NetworkNewsWire for Corporate Communications Solutions

ORHub, Inc. (ORHB) Expands Operations at Nation's Second Largest Non-Profit Hospital System

ORHub, Inc. (ORHB) Featured in NetworkNewsWire's NetworkNewsBreaks, Top 10 Mid-day Percentage Gainers, Feb 14

Stealth Technologies Inc. (STTH)

The QualityStocks Daily Newsletter would like to spotlight Stealth Technologies Inc. (STTH). Today, Stealth Technologies Inc. closed trading at $0.036127, up 3.22%, on 8,300 volume with 2 trades. The stock’s average daily volume over the past 60 days is 27,734, and its 52-week low/high is $0.015/$0.05.

Founded in 1999, Stealth Technologies Inc. (STTH) is focused on developing and marketing products that deliver cost effective, independently validated solutions for large addressable international and domestic markets. The company's primary target is identity protection and personal safety.

The Stealth Card represents the company's flagship solution for identity protection. Today there are more than 1.5 billion credit and debit cards in circulation with RFID chips, making it easier than ever for identity thieves to steal sensitive information without contact. The paper-thin Stealth Card offered by Stealth Technologies protects up to 12 RFID credit cards in a wallet without any batteries or charging requirements.

StealthIdentityTheft.com is an expansion of the company's commitment to provide first-rate identity protection solutions. The proprietary system underlying this identity protection and recovery service was designed in partnership with law enforcement officials. Utilizing the most effective methods of prevention involving a two-step process, StealthIdentityTheft.com is a superior answer to the non-stop identity theft taking place every day.

The international marketplace was infiltrated by Stealth Technologies when the company launched its 911 HELP NOW™ emergency medical alert device. Providing direct access with 911 service at a touch of a button, the device is packed with powerful features including a full year of battery life from standard AAA batteries, compact ergonomic design, 2-way voice and a durable, splash resistant design.

Stealth Mobile is the latest product offering introduced to leverage the Stealth Technologies' brand and sales channels established by the other products. Similar to the Stealth Card, Stealth Mobile prevents electronic pickpocketing. The product guards NFC transmissions emitted by cell phone devices, which can include personal information, messages and financial data.

Stealth Technologies recognizes the value of the rapid sales growth generated by these technologies and has multiple patents pending to safeguard its investments. With an expanding product suite and ongoing expansion into the identity theft protection marketplace, Stealth Technologies remains committed to its focus on increased growth and profitability. Disclaimer

Stealth Technologies Inc. Company Blog

Stealth Technologies Inc. News:

Stealth Technologies Highlights Opportunities from Attendance at Leading Real Estate, Home Staging Conference

NetworkNewsWire Releases Exclusive Audio Interview with Stealth Technologies, Inc. (STTH)

Stealth Technologies, Inc. (STTH) Engages NetworkNewsWire for Corporate Communications Solutions

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Trader Power News
(HTGM) +158.54%

2.

Marketbeat
(LJPC) +76.75%

3.

QualityStocks
(UVND) +56.00%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251